Concepedia

Usha Vyas

UV

Statistics

Publications

5

Citations

567

H-Index

5

Active since

2012

Affiliations

Kibow Biotech (United States)(Current)

SUNY Downstate Health Sciences University

Usha Vyas is an author at Kibow Biotech (United States) specializing in probiotics, life sciences, and renal disease.

Publications per year

2012–2018

5

Publications

5

Probiotics, Prebiotics, and Synbiotics: Gut and Beyond

Usha Vyas, Natarajan Ranganathan · Gastroenterology Research and Practice · 2012 · 249 citations · Full text

Life Sciences, Bioinformatics, Microbiology +15

Randomized Controlled Trial of Strain-Specific Probiotic Formulation (Renadyl) in Dialysis Patients

Natarajan Ranganathan, Bohdan Pechenyak, Usha Vyas et al. · BioMed Research International · 2014 · 147 citations · Full text

Medicine, Nephrology, Pharmacology +16

Probiotic supplements prevented oxonic acid-induced hyperuricemia and renal damage

Fernando E. García‐Arroyo, Guillermo Gonzaga, Itzel Muñoz-Jiménez et al. · PLoS ONE · 2018 · 92 citations · Full text

Life Sciences, Nutritional Sciences, Pharmacology +14

Methanol Poisoning

Tejas Desai, Aditya Sudhalkar, Usha Vyas et al. · JAMA Ophthalmology · 2013 · 69 citations

Medicine, Ophthalmology, Toxicology +17

Metabolic profiling of a chronic kidney disease cohort reveals metabolic phenotype more likely to benefit from a probiotic.

Subodh J. Saggi, Kelly Mercier, Jessica Gooding et al. · PubMed · 2017 · 10 citations

Life Sciences, Biochemistry, Nephrology +17

1–5 of 5